HLA-P and alkaline phosphatase measurement: Despite similar patterns of microbial metabolic impairment between AP subtypes, the pronounced SCFA biosynthetic deficiency observed in both BAP and HLAP groups highlights potential therapeutic targets for modulating gut microbiota function in AP management.